✨ Free AI Report
TELA Bio, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research TELA Bio, Inc.
Company Research

TELA Bio, Inc.: Business Overview, Financials & Competitive Analysis

TELA Bio, Inc. scores 6/10 on the AskCyborg Cyborg Score (Solid). TELA Bio offers meaningful innovation in surgical reconstruction but requires sustained commercial execution and reimbursement success to justify valuation. TELA Bio is an early commercial-stage medical device company with promising technology and growing market adoption, but faces execution risks, competition, and healthcare reimbursement challenges typical of the regenerative medicine.

What is TELA Bio, Inc.'s industry? TELA Bio, Inc. (telabio.com) operates in Regenerative Medicine / Medical Devices. AskCyborg classifies TELA Bio, Inc. under Regenerative Medicine / Medical Devices in its company registry.

TELA Bio is a commercial-stage regenerative medicine company developing and commercializing reconstructive implants for abdominal wall, soft tissue, and orthopedic repair. The company focuses on biologically integrate...

6/ 10Solid

Cyborg Score thesis

TELA Bio offers meaningful innovation in surgical reconstruction but requires sustained commercial execution and reimbursement...

Read the full analyst-debate transcript →
Industry Regenerative Medicine / Medical Devices
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest TELA Bio, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for TELA Bio, Inc.

AskCyborg analysts argue the bull and bear cases for TELA Bio, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
TELA Bio, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

TELA Bio, Inc. Overview

Pro stress-test →

TELA Bio is a commercial-stage regenerative medicine company developing and commercializing reconstructive implants for abdominal wall, soft tissue, and orthopedic repair. The company focuses on biologically integrated scaffolds designed to support the body's natural healing process.

Strategic Profile

Pro stress-test →

TELA Bio differentiates through its proprietary collagen-based technology platform and focus on minimally invasive reconstruction. The company is positioned to address a substantial market opportunity in surgical reconstruction with solutions that reduce complications compared to traditional approaches.

Competitive Landscape

Pro stress-test →

TELA Bio competes with established medical device companies like Johnson & Johnson, Baxter International, and Smith & Nephew, as well as emerging regenerative medicine firms. Competition centers on clinical efficacy, reimbursement coverage, surgeon adoption, and total cost of care in reconstructive surgery markets.

Industry Context

TELA Bio, Inc. operates in Regenerative Medicine / Medical Devices.

Key facts

Founded: 2014 · Headquarters: Malvern, Pennsylvania

What the analysts stress-tested

The top findings that survived the multi-agent debate for TELA Bio, Inc..

  • TELA Bio's OviTex and ARTACOLL products address large procedural markets in abdominal wall reconstruction and orthopedic repair
  • The company focuses on biologically integrated scaffolds that integrate with native tissue
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • 2025Continued commercial expansion of product portfolio
  • 2024Market adoption milestones for reconstructive implants
  • +1 moreTrack every material event for TELA Bio, Inc. as it happens. Explore monitoring →
Get alerted when TELA Bio, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

ALLODERM/MutagrafAllografts for soft tissue reconstruction→SurgimendTissue matrices for reconstruction→StratticeAcellular dermal matrix for reconstruction→

Compare TELA Bio, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

TELA Bio, Inc. operates in Regenerative Medicine / Medical Devices. See how the rest of the sector scores on the Cyborg framework.

Browse Regenerative Medicine / Medical Devices research →
NEW · MCP server

Ask your AI assistant about TELA Bio, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare TELA Bio, Inc. and its top competitor on Cyborg Score”
“What did TELA Bio, Inc. do this quarter?”
“Is TELA Bio, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does TELA Bio, Inc. do?+
TELA Bio is a commercial-stage regenerative medicine company developing and commercializing reconstructive implants for abdominal wall, soft tissue, and orthopedic repair. The company focuses on biologically integrate...
What is TELA Bio, Inc.'s Cyborg Score?+
TELA Bio, Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are TELA Bio, Inc.'s main competitors?+
Named competitors include ALLODERM/Mutagraf, Surgimend, Strattice. The full competitive landscape is in the AskCyborg report.
How can I get the full TELA Bio, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the TELA Bio, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track TELA Bio, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Regenerative Medicine research

Companies in the same sector and named competitors, ranked by Cyborg Score.

6Humacyte, Inc.5Organogenesis Holdings Inc.4Longeveron Inc.